Rule 36 India Import in Qatar
How the rule 36 india import pathway operates in Qatar.
About Rule 36 India Import
India's personal-use import pathway under Rule 36 of D&C Rules.
How Rule 36 India Import works in Qatar
Qatar's MoPH permits unregistered drug import under a named-patient pathway with physician and MoPH approval; Hamad Medical Corp frequently sponsors.
Patients in Qatar seeking access under Rule 36 India Import typically follow this flow: a licensed physician in Qatar issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Qatar
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.